Regenesis Meditech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 1 Month
- Last Filing with ROC 31 Mar 2021
About Regenesis Meditech
Regenesis Meditech Private Limited (RMPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 January 2016 (Nine years and one month 7 days old ). Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Hashmatulla Khan and Nayab Khan serve as directors at the Company.
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100MP2016PTC035248
- Company No.
035248
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jan 2016
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
What products or services does Regenesis Meditech Private Limited offer?
Regenesis Meditech Private Limited offers a wide range of products and services, including Herbal Capsules, Ashwagandha Capsules, Herbal Juice, Aloe Vera Juice, Herbal Cough Syrup, Ayurvedic Cough Syrup, Ayurvedic & Herbal Extracts, Herbal Extracts, Ayurvedic & Herbal Health Supplement, Herbal Supplements.
Who are the key members and board of directors at Regenesis Meditech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hashmatulla Khan  | Director | 19-Jan-2016 | Current |
| Nayab Khan | Director | 20-Sep-2017 | Current |
Financial Performance of Regenesis Meditech.
Regenesis Meditech Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Regenesis Meditech?
In 2017, Regenesis Meditech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Regenesis Meditech?
Unlock and access historical data on people associated with Regenesis Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Regenesis Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Regenesis Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
